Page last updated: 2024-11-13

buprenorphine-3-o-glucuronide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

buprenorphine-3-O-glucuronide: RN given refers to (5alpha,7alpha-(S))-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID92131860
MeSH IDM0143441

Synonyms (19)

Synonym
b-3-g
unii-l7fym9gi97
101224-22-0
l7fym9gi97 ,
buprenorphine-3-o-glucuronide
beta-d-glucopyranosiduronic acid, (5alpha,7alpha-(s))-17-(cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-7-(1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-ethenomorphinan-3-yl
buprenorphine 3-glucuronide
buprenophine beta-d-glucuronide
W-200647
buprenorphine 3-.beta.-d-glucuronide
.beta.-d-glucopyranosiduronic acid, (5.alpha.,7.alpha.)-17-(cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-7-((1s)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-ethenomorphinan-3-yl
buprenorphine-3b-d-glucuronide
buprenorphine 3-beta-d-glucuronide; buprenorphine 3-glucuronide; buprenorphine 3-?-d-glucuronide; buprenorphine glucuronide; (5?,7?)-17-(cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-7-[(1s)-1-hydroxy-1,2,2-trimethylpropyl]-6-methoxy-6,14-ethenomorphinan-3-y
buprenorphine 3-beta-d-glucuronide 0.1 mg/ml in methanol
Q27282811
(2s,3s,4s,5r,6s)-6-[[(1s,2s,6r,14r,15r,16r)-5-(cyclopropylmethyl)-16-[(2s)-2-hydroxy-3,3-dimethylbutan-2-yl]-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
buprenorphine-3-beta-d-glucuronide, 0.1mg/ml in acetonitrile/water : 1/1
buprenorphine-3-beta-d-glucuronide
buprenorphine-3-beta-d-glucuronide, 1mg/ml in acetonitrile/water : 1/1
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (8.33)18.7374
1990's1 (8.33)18.2507
2000's6 (50.00)29.6817
2010's4 (33.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.50

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.50 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index5.14 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.50)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (8.33%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (91.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]